These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 34283065)
21. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma. Eggert T; Greten TF Digestion; 2017; 96(1):1-4. PubMed ID: 28605745 [TBL] [Abstract][Full Text] [Related]
22. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress. Brown ZJ; Hewitt DB; Pawlik TM Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184 [TBL] [Abstract][Full Text] [Related]
23. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma. Mondaca S; Yarmohammadi H; Kemeny NE Surg Oncol Clin N Am; 2019 Oct; 28(4):717-729. PubMed ID: 31472915 [TBL] [Abstract][Full Text] [Related]
24. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747 [TBL] [Abstract][Full Text] [Related]
25. Advances in Diagnostic and Interventional Radiology in Hepatocellular Carcinoma. Öcal O; Rössler D; Ricke J; Seidensticker M Dig Dis; 2022; 40(4):458-467. PubMed ID: 34348282 [TBL] [Abstract][Full Text] [Related]
26. Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. Choi JH; Ro JY Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009374 [TBL] [Abstract][Full Text] [Related]
27. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study. Yang Z; Shi G Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762 [TBL] [Abstract][Full Text] [Related]
28. Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management. Ye L; Schneider JS; Ben Khaled N; Schirmacher P; Seifert C; Frey L; He Y; Geier A; De Toni EN; Zhang C; Reiter FP Liver Cancer; 2024 Feb; 13(1):6-28. PubMed ID: 38344449 [TBL] [Abstract][Full Text] [Related]
29. Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies. Gorji L; Aoun H; Critchfield J; Al Hallak N; Beal EW Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835420 [TBL] [Abstract][Full Text] [Related]
30. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Lauterio A; De Carlis R; Centonze L; Buscemi V; Incarbone N; Vella I; De Carlis L Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359560 [TBL] [Abstract][Full Text] [Related]
31. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620 [TBL] [Abstract][Full Text] [Related]
32. Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. Uppal DS; Wang AY World J Gastrointest Endosc; 2015 Jun; 7(7):675-87. PubMed ID: 26140095 [TBL] [Abstract][Full Text] [Related]